ArticleBMJ open2026
Efficacy and safety of long-acting injectable paliperidone palmitate 1-month and 3-month formulations in the maintenance treatment of schizophrenia: a single-arm, open-label, interventional study in Rwandan healthcare settings.
Rutakayile Bizoza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.